Ventas (VTR) Projected to Post Earnings on Tuesday

Ventas (NYSE:VTR) is anticipated to announce its Q3 2026 results after the market closes on Tuesday, October 27th. Analysts expect Ventas to post earnings of $0.1621 per share and revenue of $1.77 billion for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating the consensus estimate of $0.96 by $0.01. The firm had revenue of $1.73 billion for the quarter, compared to analysts’ expectations of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%. The firm’s revenue was up 21.7% compared to the same quarter last year. During the same period last year, the firm earned $0.87 EPS. On average, analysts expect Ventas to post $3.89 EPS for the current fiscal year and $4.28 EPS for the next fiscal year.

Ventas Stock Up 0.1%

Shares of Ventas stock opened at $86.86 on Monday. The business’s fifty day moving average price is $87.89 and its two-hundred day moving average price is $88.10. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The company has a market capitalization of $44.55 billion, a P/E ratio of 160.85, a PEG ratio of 3.39 and a beta of 0.72. Ventas has a 1-year low of $68.15 and a 1-year high of $101.60.

Ventas Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas’s dividend payout ratio is presently 385.19%.

Analyst Ratings Changes

A number of brokerages have recently commented on VTR. Citigroup raised their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Jefferies Financial Group reduced their price objective on shares of Ventas from $102.00 to $95.00 in a report on Monday, October 12th. Barclays decreased their target price on shares of Ventas from $102.00 to $91.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 13th. Royal Bank Of Canada increased their target price on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, Argus raised their target price on shares of Ventas from $92.00 to $98.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Eighteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Ventas has an average rating of “Moderate Buy” and an average price target of $98.91.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.